Literature DB >> 17112449

Surgical management of upper tract transitional cell carcinoma.

Alison M Lake1, William W Roberts.   

Abstract

Upper tract transitional cell carcinoma (TCC) accounts for approximately 5% of urothelial tumors. Surgical therapy for upper tract TCC is based on tumor grade, stage, location, and confounding factors of individual cases. Options for treatment range from minimally invasive procedures, such as ureteroscopy, to open nephroureterectomy. Laparoscopic nephroureterectomy is progressively eclipsing open nephroureterectomy in the surgical management of upper tract TCC. This article discusses the surgical options for managing upper tract TCC and their considerations for use.

Entities:  

Mesh:

Year:  2006        PMID: 17112449     DOI: 10.6004/jnccn.2006.0084

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  1 in total

1.  Upper tract urothelial carcinoma: impact of time to surgery.

Authors:  Debasish Sundi; Robert S Svatek; Vitaly Margulis; Christopher G Wood; Surena F Matin; Colin P Dinney; Ashish M Kamat
Journal:  Urol Oncol       Date:  2010-09-25       Impact factor: 3.498

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.